Delivery Order SPE2DB20D2014-SPE2DB24FA97Z
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product GAMUNEX-C, a 40 gram/400 ml vial. The delivery order has a ceiling value of $14,427.24 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,648.20, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The contract is a firm fixed price type with a period of performance through December 19, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,161.68, is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a pharmaceutical product, with a completion date of May 1, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.46 firm fixed-price contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, with a completion date of December 30, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with a potential value of $16,397.85. The contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization that provides a wide range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $24,045.60 firm fixed-price contract is for the delivery of 4,566,102,267 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML. The contract has a period of performance through November 5, 2024 and was awarded on October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,327.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, with a performance period through May 9, 2025. The contract is not set aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of GAMUNEX-C 20 gram/200 ML vials in support of military treatment programs and facilities. The potential value of this contract is $3,573.75, with a completion date of March 5, 2024. No set-aside designation was used for this award....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $115,417.92 firm-fixed-price contract is for the supply of GAMUNEX-C 40 gram/400 mL vials, a specialized immunoglobulin medication. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML pharmaceutical products. This $16,397.85 contract has a completion date of March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA that has a potential value...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA97ZDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $23,869.12, is for the supply of GAMUNEX-C 20 gram/200 ml vials to support military treatment programs and facilities. The contract has a completion date of February 26, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp holds multiple federal contracts with DLA and the Department of Justice to provide pharmaceuticals, medical supplies, and related distribution services. This delivery order contract is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 2/2/24 |